Edward Lee

Title: Edward Lee: Innovator in Pharmaceutical Formulations

Introduction

Edward Lee is a notable inventor based in Alpharetta, GA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable formulations. With a total of 2 patents, his work focuses on innovative solutions for medical treatments.

Latest Patents

One of Edward Lee's latest patents is for injectable triamcinolone formulations. This patent relates to pharmaceutical suspensions of triamcinolone acetonide, detailing methods of producing these suspensions and their applications. The formulations are designed to be stable and suitable for administration via suprachoroidal injection using a 30-gauge microneedle. Another significant patent involves an anhydrous crystalline free base form of 6-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzoxazole. This crystalline form is particularly useful in treating infections caused by Picornaviridae, such as human rhinovirus (HRV). The patent also includes methods for manufacturing this crystalline form, which may involve micronizing the compound particles and using pharmaceutical compositions like tablets or suspensions.

Career Highlights

Edward Lee has worked with several prominent companies in the pharmaceutical industry, including Aviragen Therapeutics, Inc. and Clearside Biomedical, Inc. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Edward has collaborated with notable professionals in his field, including David McAllister and Andrew Trigwell. These collaborations have likely enhanced his research and development efforts.

Conclusion

Edward Lee is a distinguished inventor whose work in pharmaceutical formulations has the potential to impact medical treatments significantly. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.